On October 12th, the initial meeting of Evidence from Clinical Trials of the Chinese Medicine was held in LZU, about 10 chief fascicules editors and representatives from Beijing, Gansu, Guangdong, and other regions attending the meeting. Prof. Wu Taixiang from SCU and Prof. Yang Kehu from LZU hosted the meeting.
On the meeting, the host announced the initiation of the editing of Evidence from Clinical Trials of the Chinese Medicine. Experts presented at the meeting held discussions and reached agreement on the recruitment of chief editors, the selection of the editorial board members, principles of editing, as well as the working schedule.
The theme of editing Evidence from Clinical Trials of the Chinese Medicine was selected by Springer Group, aiming to form an international authorized information and evidence source of a transparent evaluation system of clinical trials of the Chinese Medicine. The edition of this series of books is an important chance to introduce the research achievements of Chinese Medicine to the whole world, and is expected to finish before April, 2018. The series of books will be issued by Springer Group in English globally.
(Translated by Wen Jing; roofread by Gao Pei)
